A Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate Cancer | MicrobiomeTrials← Back to trialsNCT06568094
A Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate Cancer
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2024-09-25Est. Completion: 2026-06
Enrollment target: 100 participants Locations- The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China
- Shanghai Jiao Tong University School of Medicine, Renji Hospital, Shanghai, Shanghai Municipality, China
Other microbiome trials you might be interested in
Localised Prostate Cancer
The goal of this randomised clinical trial is to assess whether personalised treatment counselling can improve the decis…
Multiple LocationsEst. completion Nov 2027
Metastatic Breast CancerMetastatic Prostate CancerGRPR-Targeted Molecular ImagingTheranostic RadiopharmaceuticalsCancerActive CancerTheranosticRadiopharmaceutical
This is an open-label, first-in-human, exploratory Phase 0 study evaluating the safety and diagnostic imaging performanc…
Perth, AustraliaEst. completion May 30, 2028